Table S1. List of Technical expert panel members. Table S2. Search strategy. Table S3. The most frequently reported outcomes in evaluated RCTs. Table S4. Description of cohort studies by intervention. Table S5. Description of all RCTs by intervention. Table S6. Flavan-3ol content by intervention. Table S7. Description of outcomes reported in apple intervention studies. Table S8. Description of outcomes reported in berries intervention studies. Table S9. Description of outcomes reported in black tea intervention studies. Table S10. Description of outcomes reported in chocolate intervention studies. Table S11. Description of outcomes reported in cinnamon intervention studies. Table S12. Description of outcomes reported in cranberry interventi...
Table S1. Detailed search strategies. Table S2. Excluded articles with reasons at the stage of eligi...
Effects of carbohydrate interventions as compared to placebo on time required to finish a time trial...
Table S1. Baseline characteristics in ACS QUIK patients by intervention and control group among 12,6...
Dietary intakes for the MTHFR risk, MTHFR non-risk and control groups at M0 and M3. Table S2. Dietar...
Table S1. Concomitant medications. Table S2. Average daily dietary intake. (DOCX 14 kb
Figure S1. Flow diagram of study selection; Table S1. Primary and secondary endpoints, inclusion and...
SPIRIT 2013 checklist: recommended items to address in a clinical trial protocol and related documen...
Study design; Additional Fig. 1. Study design schematic; Additional Fig. 2. Mean change from baselin...
Appendix. Search Strategy. Table S1. Studies Characteristics. Table S2. Outcomes reported in individ...
CONSORT 2010 checklist of information to include when reporting a randomized trial. (DOC 223 kb
Relative Risk of Cardiovascular Disease, according to quartiles of toenail mercury, among case parti...
Table S1. Changes in the dietary intake, physical activity and fatty acid composition of the partici...
Table S1. Characteristics of included cohort studies reporting CVDs risk and fat intake. (DOCX 82 kb
Table S1. Pivotal trials with at least one postapproval trial with a patient-relevant outcome. (XLSX...
Table S1. Baseline demographics and psychosocial factors of participants in the INFORM trial, by tho...
Table S1. Detailed search strategies. Table S2. Excluded articles with reasons at the stage of eligi...
Effects of carbohydrate interventions as compared to placebo on time required to finish a time trial...
Table S1. Baseline characteristics in ACS QUIK patients by intervention and control group among 12,6...
Dietary intakes for the MTHFR risk, MTHFR non-risk and control groups at M0 and M3. Table S2. Dietar...
Table S1. Concomitant medications. Table S2. Average daily dietary intake. (DOCX 14 kb
Figure S1. Flow diagram of study selection; Table S1. Primary and secondary endpoints, inclusion and...
SPIRIT 2013 checklist: recommended items to address in a clinical trial protocol and related documen...
Study design; Additional Fig. 1. Study design schematic; Additional Fig. 2. Mean change from baselin...
Appendix. Search Strategy. Table S1. Studies Characteristics. Table S2. Outcomes reported in individ...
CONSORT 2010 checklist of information to include when reporting a randomized trial. (DOC 223 kb
Relative Risk of Cardiovascular Disease, according to quartiles of toenail mercury, among case parti...
Table S1. Changes in the dietary intake, physical activity and fatty acid composition of the partici...
Table S1. Characteristics of included cohort studies reporting CVDs risk and fat intake. (DOCX 82 kb
Table S1. Pivotal trials with at least one postapproval trial with a patient-relevant outcome. (XLSX...
Table S1. Baseline demographics and psychosocial factors of participants in the INFORM trial, by tho...
Table S1. Detailed search strategies. Table S2. Excluded articles with reasons at the stage of eligi...
Effects of carbohydrate interventions as compared to placebo on time required to finish a time trial...
Table S1. Baseline characteristics in ACS QUIK patients by intervention and control group among 12,6...